Reading time: 3 minutes Tala Tayoun Antitumor antibody-drug conjugates (ADCs) are a class of therapeutic molecules used in cancer therapy. Their main purpose is to channel the drug to a specific tumor site, kill cancer cells while sparing healthy cells and minimizing collateral damage [1]. ADC comprises of three key components: (1) an antibody, (2)... Continue Reading →